Lung Cancer News

Having been exposed to benzene during work heightened the odds for lung cancer development, according to results published in American Journal of Respiratory and Critical Care Medicine.

In a study of patients with small cell lung cancer and idiopathic pulmonary fibrosis receiving carboplatin, etoposide and nintedanib, the primary endpoint was met, according to results published in Annals of the American Thoracic Society.

A universal screening and opt-out referral strategy may reduce disparities in tobacco treatment access and increase use of smoking cessation services by people with cancer, according to results of a qualitative improvement study.

In this edition, atezolizumab benefits PD-L1-selected patients with NSCLC, risks persist with e-cigarette use after quitting tobacco smoking and more.

Among patients with moderate-risk peripheral lung nodules, a robotic bronchoscopy system had high diagnostic yield, according to results published in Respirology.

CHICAGO — Updated survival data from the randomized phase 3 IMpower010 continued to support adjuvant atezolizumab for patients with stage II to stage IIIA PD-L1-expressing non-small cell lung cancer, according to researchers.

Cancer survivors with the lowest socioeconomic status appeared twice as likely to die of CVD than those with the highest household incomes, according to a study published in European Heart Journal – Quality of Care and Clinical Outcomes.

Individuals who smoke tobacco using a waterpipe had a higher risk for death from multiple cancer types compared with those who never smoked, according to data from an ongoing cohort study published in JAMA Oncology.

CHICAGO — Most individuals with cancer who used an AI-based nutritional platform reported the application helped them regulate their diets and improved their quality of life, according to study results presented at ASCO Annual Meeting.

Compared with non-Hispanic white individuals, patients from racial and ethnic minority groups experienced similar clinical benefits when participating in phase 1 trials for advanced cancers, data published in JAMA Network Open showed.